Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Prime Medicine Inc (PRME)

Prime Medicine Inc (PRME)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.40 +0.10 (+4.35%) 03/07/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.40 unch (unch) 16:02 ET
Quote Overview for Fri, Mar 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.23
Day High
2.47
Open 2.30
Previous Close 2.30 2.30
Volume 1,173,800 1,173,800
Avg Vol 1,164,660 1,164,660
Stochastic %K 17.47% 17.47%
Weighted Alpha -72.07 -72.07
5-Day Change -0.12 (-4.76%) -0.12 (-4.76%)
52-Week Range 2.12 - 8.58 2.12 - 8.58
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 314,786
  • Shares Outstanding, K 131,161
  • Annual Sales, $ 2,980 K
  • Annual Income, $ -195,880 K
  • EBIT $ -158 M
  • EBITDA $ -204 M
  • 60-Month Beta 1.85
  • Price/Sales 101.13
  • Price/Cash Flow N/A
  • Price/Book 1.97

Options Overview Details

View History
  • Implied Volatility 325.75% ( +31.50%)
  • Historical Volatility 86.88%
  • IV Percentile 90%
  • IV Rank 28.18%
  • IV High 1,083.12% on 02/12/25
  • IV Low 28.53% on 08/23/24
  • Put/Call Vol Ratio 17.50
  • Today's Volume 37
  • Volume Avg (30-Day) 209
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 5,436
  • Open Int (30-Day) 4,958

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.32
  • Number of Estimates 5
  • High Estimate -0.28
  • Low Estimate -0.35
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.12 +13.21%
on 03/04/25
Period Open: 2.47
3.36 -28.57%
on 02/19/25
-0.07 (-2.83%)
since 02/07/25
3-Month
2.12 +13.21%
on 03/04/25
Period Open: 3.27
3.59 -33.15%
on 01/06/25
-0.87 (-26.61%)
since 12/06/24
52-Week
2.12 +13.21%
on 03/04/25
Period Open: 8.14
8.58 -72.03%
on 03/08/24
-5.74 (-70.52%)
since 03/07/24

Most Recent Stories

More News
Labour Figures Due Next Week

Monday Economic Lookahead S&P final U.S. manufacturing PMI (Feb.) Construction spending ...

TGT : 115.08 (+0.90%)
GTLB : 56.38 (-3.21%)
CRWD : 333.50 (-4.09%)
AVGO : 194.96 (+8.64%)
CURA.TO : 1.48 (-1.33%)
VEEV : 246.80 (+4.51%)
PLUG : 1.7800 (+7.88%)
OKTA : 112.44 (+1.10%)
SE : 135.69 (-2.49%)
COST : 964.31 (-6.07%)
GCO : 27.11 (-16.33%)
CRC : 41.49 (+1.27%)
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

PRME : 2.40 (+4.35%)
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

PRME : 2.40 (+4.35%)
Analyst: Sell ‘Magnificent 7’ Stocks and Buy These 3 Dividend Stocks Instead

Analysts at Miramar Capital are advising investors to sell “Magnificent 7” and instead invest in lower-valuation, dividend-paying healthcare stocks.

NVDA : 112.69 (+1.92%)
META : 625.66 (-0.36%)
GOOGL : 173.86 (+0.88%)
AAPL : 239.07 (+1.59%)
$SPX : 5,770.20 (+0.55%)
MRK : 94.65 (+0.69%)
ABBV : 214.29 (+1.68%)
BMY : 61.09 (+1.51%)
MSFT : 393.31 (-0.90%)
TSLA : 262.67 (-0.30%)
ABT : 137.14 (+1.53%)
AMZN : 199.25 (-0.72%)
Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference

PRME : 2.40 (+4.35%)
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

PRME : 2.40 (+4.35%)
Prime Medicine to Participate in Upcoming Investor Conferences

PRME : 2.40 (+4.35%)
12 High-Growth Stocks That Could Deliver Parabolic Returns

These 12 innovative companies could deliver exponential returns over the next quarter century.

NVDA : 112.69 (+1.92%)
NVTS : 2.54 (+2.01%)
VRTX : 488.29 (+0.53%)
RKLB : 18.80 (+0.75%)
LUNR : 8.77 (-22.11%)
SERV : 7.43 (-6.19%)
ACHR : 7.52 (-0.53%)
TSLA : 262.67 (-0.30%)
CRSP : 45.53 (+5.13%)
SOUN : 9.74 (+1.99%)
APLD : 7.26 (+3.71%)
TM : 190.18 (+1.42%)
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

PRME : 2.40 (+4.35%)
Why I Keep Buying These 14 Incredible Growth Stocks

This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries.

NVDA : 112.69 (+1.92%)
NVTS : 2.54 (+2.01%)
RKLB : 18.80 (+0.75%)
KTOS : 27.29 (+1.53%)
LUNR : 8.77 (-22.11%)
ASPN : 7.95 (+1.92%)
TSM : 177.10 (+0.71%)
ACHR : 7.52 (-0.53%)
CRSP : 45.53 (+5.13%)
GE : 193.85 (-1.12%)
JOBY : 6.62 (-0.30%)
PRME : 2.40 (+4.35%)

Business Summary

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 2.74
2nd Resistance Point 2.60
1st Resistance Point 2.50
Last Price 2.40
1st Support Level 2.27
2nd Support Level 2.13
3rd Support Level 2.03

See More

52-Week High 8.58
Fibonacci 61.8% 6.11
Fibonacci 50% 5.35
Fibonacci 38.2% 4.59
Last Price 2.40
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
How to Trade Futures Spreads Like a Pro – Unlock Powerful Market Insights